Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Paper Tigers Or Paper Bullets? FDA Curbs Repeat Warning Letters, Violations

This article was originally published in The Gray Sheet

Executive Summary

Enforcement policies under way within FDA's Office of the Chief Counsel could eliminate the practice of issuing multiple compliance warning letters, according to agency officials

You may also be interested in...



Device DTC Guidances Aim To Hone Enforcement, Stimulate Patient Education

FDA's draft guidances for consumer advertising establish explicit standards to which the agency will hold medical device manufacturers accountable, according to Commissioner Mark McClellan

Device DTC Guidances Aim To Hone Enforcement, Stimulate Patient Education

FDA's draft guidances for consumer advertising establish explicit standards to which the agency will hold medical device manufacturers accountable, according to Commissioner Mark McClellan

Philips Medical Systems Incurs Second Warning Letter Since August

Corrective actions related to a warning letter Philips Medical Systems received Oct. 16 will be addressed during a meeting between the company and FDA the week of Nov. 3

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT017500

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel